187 related articles for article (PubMed ID: 34152493)
1. Interleukin-10-592 polymorphism: impact on relapse and survival after allogeneic hematopoietic stem cell transplantation in children with hematological malignancies.
Schwenk L; Wittig S; Gruhn B
J Cancer Res Clin Oncol; 2022 Apr; 148(4):985-991. PubMed ID: 34152493
[TBL] [Abstract][Full Text] [Related]
2. CTLA-4 polymorphisms: influence on transplant-related mortality and survival in children undergoing allogeneic hematopoietic stem cell transplantation.
Hammrich J; Wittig S; Ernst T; Gruhn B
J Cancer Res Clin Oncol; 2018 Mar; 144(3):587-592. PubMed ID: 29335768
[TBL] [Abstract][Full Text] [Related]
3. Association of recipient and donor interleukin 6 polymorphisms 174 and 597 with outcome after allogeneic hematopoietic stem cell transplantation in children.
Wetzel L; Wittig S; Gruhn B
J Cancer Res Clin Oncol; 2022 Jan; 148(1):255-265. PubMed ID: 34120222
[TBL] [Abstract][Full Text] [Related]
4. [Effects of IL10-592 locus of AA genotype on the incidence of aGVHD and survival after HLA-matched unrelated allogeneic hematopoietic stem cell transplantation].
Yang ZL; Qiu QC; Ding ZX; Pan ZJ; Zhao QQ; He J
Zhonghua Xue Ye Xue Za Zhi; 2016 May; 37(5):372-6. PubMed ID: 27210870
[TBL] [Abstract][Full Text] [Related]
5. Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
Kielsen K; Enevold C; Heilmann C; Sengeløv H; Pedersen AE; Ryder LP; Müller K
Front Immunol; 2018; 9():109. PubMed ID: 29456530
[TBL] [Abstract][Full Text] [Related]
6. CTLA-4 polymorphism rs231775: Influence on relapse and survival after allogeneic hematopoietic stem cell transplantation in childhood.
Hammrich J; Wittig S; Ernst T; Gruhn B
Eur J Haematol; 2019 Mar; 102(3):251-255. PubMed ID: 30465728
[TBL] [Abstract][Full Text] [Related]
7. [Association between IL-10 Gene -592(C→A) (rs1800872) SNP and GVHD after Allogeneic Hematopoietic Stem Cell Transplantation in Children].
Lin JY; Wang K; Gao C; Liu SG; Qin MQ; Wang B; Zhu GH; Zheng HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):573-579. PubMed ID: 30998173
[TBL] [Abstract][Full Text] [Related]
8. The effects of gene polymorphisms on susceptibility to acute GVHD and survival of allogeneic HSCT recipients: IL-10 gene polymorphisms as a more accessible target to predict prognosis.
Granero Farias M; Andrade Dos Santos C; de Mello Vicente B; Habigzang M; de Oliveira da Silva P; Emerim Lemos N; Dieter C; Paz A; Esteves Daudt L
Hum Immunol; 2020 Jan; 81(1):18-25. PubMed ID: 31889553
[TBL] [Abstract][Full Text] [Related]
9. [IL-18 single nucleotide polymorphisms in hematologic malignancies with HLA matched sibling donor allogeneic hematopoietic stem cell transplantation].
Cai X; Song A; Wang H; Zhang P; Zhang G; Yang F; Wei J; Ma Q; Yan Z; Jiang E; Huang Y; Yang D; Wang M; He Y; Han M; Feng S
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):215-20. PubMed ID: 24666487
[TBL] [Abstract][Full Text] [Related]
10. P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.
Lee KH; Park SS; Kim I; Kim JH; Ra EK; Yoon SS; Hong YC; Park S; Kim BK
Haematologica; 2007 May; 92(5):651-7. PubMed ID: 17488689
[TBL] [Abstract][Full Text] [Related]
11. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
[TBL] [Abstract][Full Text] [Related]
12. Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation.
Zhou H; Bao X; Wu X; Tang X; Wang M; Wu D; He J
Biol Blood Marrow Transplant; 2014 Jan; 20(1):98-105. PubMed ID: 24516895
[TBL] [Abstract][Full Text] [Related]
13. Effect of IL-2 polymorphism rs2069762 on single-unit cord blood transplant outcomes.
Konuma T; Hamatani-Asakura M; Monna-Oiwa M; Kato S; Isobe M; Yokoyama K; Takahashi S; Nannya Y
Cytokine; 2024 Jul; 179():156636. PubMed ID: 38718489
[TBL] [Abstract][Full Text] [Related]
14. Association between interleukin-10 promoter gene polymorphisms and acute graft-versus-host disease after hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Cho IH; Song YK; Kim MG; Han N; Kim T; Oh JM
Hematology; 2015 Apr; 20(3):121-8. PubMed ID: 25116082
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
16. Association of cytokine gene polymorphisms with the complications of allogeneic haematopoietic stem cell transplantation.
Dukat-Mazurek A; Bieniaszewska M; Hellmann A; Moszkowska G; Trzonkowski P
Hum Immunol; 2017 Nov; 78(11-12):672-683. PubMed ID: 28987962
[TBL] [Abstract][Full Text] [Related]
17. Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation.
Frick M; Chan W; Arends CM; Hablesreiter R; Halik A; Heuser M; Michonneau D; Blau O; Hoyer K; Christen F; Galan-Sousa J; Noerenberg D; Wais V; Stadler M; Yoshida K; Schetelig J; Schuler E; Thol F; Clappier E; Christopeit M; Ayuk F; Bornhäuser M; Blau IW; Ogawa S; Zemojtel T; Gerbitz A; Wagner EM; Spriewald BM; Schrezenmeier H; Kuchenbauer F; Kobbe G; Wiesneth M; Koldehoff M; Socié G; Kroeger N; Bullinger L; Thiede C; Damm F
J Clin Oncol; 2019 Feb; 37(5):375-385. PubMed ID: 30403573
[TBL] [Abstract][Full Text] [Related]
18. Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies.
Xiao H; Luo Y; Lai X; Fu S; Shi J; Tan Y; He J; Xie W; Zheng W; Wang LM; Zhang L; Liu L; Ye X; Yu X; Cai Z; Lin M; Huang H
Haematologica; 2012 Dec; 97(12):1804-12. PubMed ID: 22733023
[TBL] [Abstract][Full Text] [Related]
19. Effect of FOXP3 polymorphism on the clinical outcomes after allogeneic hematopoietic stem cell transplantation in pediatric acute leukemia patients.
Piao Z; Kim HJ; Choi JY; Hong CR; Lee JW; Kang HJ; Park KD; Shin HY
Int Immunopharmacol; 2016 Feb; 31():132-9. PubMed ID: 26735609
[TBL] [Abstract][Full Text] [Related]
20. Association of IL-1β -511 polymorphism with severe veno-occlusive disease in pediatric-matched allogeneic hematopoietic stem cell transplantation.
Elbahlawan L; McArthur J; Quasney MW; Pei D; Srivastava K; Dahmer MK; Barfield R
J Pediatr Hematol Oncol; 2012 Apr; 34(3):175-9. PubMed ID: 22395218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
